Literature DB >> 28537482

* Programmed Platelet-Derived Growth Factor-BB and Bone Morphogenetic Protein-2 Delivery from a Hybrid Calcium Phosphate/Alginate Scaffold.

Emily A Bayer1,2, Jahnelle Jordan1, Abhijit Roy1,2, Riccardo Gottardi3,4,5, Morgan V Fedorchak1,2,3,6, Prashant N Kumta1,2,3,7,8, Steven R Little1,2,3,9.   

Abstract

Bone tissue engineering requires the upregulation of several regenerative stages, including a critical early phase of angiogenesis. Previous studies have suggested that a sequential delivery of platelet-derived growth factor (PDGF) to bone morphogenetic protein-2 (BMP-2) could promote angiogenic tubule formation when delivered to in vitro cocultures of human umbilical vein endothelial cells (HUVECs) and human mesenchymal stem cells (hMSCs). However, it was previously unclear that this PDGF to BMP-2 delivery schedule will result in cell migration into the scaffolding system and affect the later expression of bone markers. Additionally, a controlled delivery system had not yet been engineered for programmed sequential presentation of this particular growth factor. By combining alginate matrices with calcium phosphate scaffolding, a programmed growth factor delivery schedule was achieved. Specifically, a combination of alginate microspheres, alginate hydrogels, and a novel blend of resorbable calcium phosphate-based cement (ReCaPP) was used. PDGF and BMP-2 were sequentially released from this hybrid calcium phosphate/alginate scaffold with the desired 3-day overlap in PDGF to BMP-2 delivery. Using a three-dimensional coculture model, we observed that this sequence of PDGF to BMP-2 delivery influenced both cellular infiltration and alkaline phosphatase (ALP) expression. It was found that the presence of early PDGF delivery increased the distance of cell infiltration into the calcium phosphate/alginate scaffolding in comparison to early BMP-2 delivery and simultaneous PDGF+BMP-2 delivery. It was also observed that hMSCs expressed a greater amount of ALP+ staining in response to scaffolds delivering the sequential PDGF to BMP-2 schedule, when compared with scaffolds delivering no growth factor, or PDGF alone. Importantly, hMSCs cultured with scaffolds releasing the PDGF to BMP-2 schedule showed similar amounts of ALP staining to hMSCs cultured with BMP-2 alone, suggesting that the sequential schedule of PDGF to BMP-2 presentation promotes differentiation of hMSCs toward an osteoblast phenotype while also increasing cellular infiltration of the scaffold.

Entities:  

Keywords:  3D coculture; angiogenesis; bone regeneration; controlled delivery; growth factors

Mesh:

Substances:

Year:  2017        PMID: 28537482      PMCID: PMC5729879          DOI: 10.1089/ten.TEA.2017.0027

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  43 in total

Review 1.  Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review.

Authors:  Susmita Bose; Solaiman Tarafder
Journal:  Acta Biomater       Date:  2011-11-20       Impact factor: 8.947

Review 2.  Strategies for controlled delivery of growth factors and cells for bone regeneration.

Authors:  Tiffany N Vo; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-02-04       Impact factor: 15.470

Review 3.  State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective.

Authors:  Dietmar Werner Hutmacher; Jan Thorsten Schantz; Christopher Xu Fu Lam; Kim Cheng Tan; Thiam Chye Lim
Journal:  J Tissue Eng Regen Med       Date:  2007 Jul-Aug       Impact factor: 3.963

Review 4.  Extracellular matrix-inspired growth factor delivery systems for bone regeneration.

Authors:  Mikaël M Martino; Priscilla S Briquez; Kenta Maruyama; Jeffrey A Hubbell
Journal:  Adv Drug Deliv Rev       Date:  2015-04-17       Impact factor: 15.470

Review 5.  Growth factor delivery: how surface interactions modulate release in vitro and in vivo.

Authors:  William J King; Paul H Krebsbach
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

6.  Bioluminescent and micro-computed tomography imaging of bone repair induced by fibrin-binding growth factors.

Authors:  Olaia F Vila; Mikaël M Martino; Laura Nebuloni; Gisela Kuhn; Soledad Pérez-Amodio; Ralph Müller; Jeffrey A Hubbell; Nuria Rubio; Jerónimo Blanco
Journal:  Acta Biomater       Date:  2014-06-04       Impact factor: 8.947

Review 7.  Studies of bone morphogenetic protein-based surgical repair.

Authors:  Kevin W-H Lo; Bret D Ulery; Keshia M Ashe; Cato T Laurencin
Journal:  Adv Drug Deliv Rev       Date:  2012-04-02       Impact factor: 15.470

8.  Positive Charge of "Sticky" Peptides and Proteins Impedes Release From Negatively Charged PLGA Matrices.

Authors:  Stephen C Balmert; Andrew C Zmolek; Andrew J Glowacki; Timothy D Knab; Sam N Rothstein; Joseph M Wokpetah; Morgan V Fedorchak; Steven R Little
Journal:  J Mater Chem B       Date:  2015-06-21       Impact factor: 6.331

Review 9.  The challenge of establishing preclinical models for segmental bone defect research.

Authors:  Johannes C Reichert; Siamak Saifzadeh; Martin E Wullschleger; Devakara R Epari; Michael A Schütz; Georg N Duda; Hanna Schell; Martijn van Griensven; Heinz Redl; Dietmar W Hutmacher
Journal:  Biomaterials       Date:  2009-02-10       Impact factor: 12.479

Review 10.  Use and efficacy of bone morphogenetic proteins in fracture healing.

Authors:  Suzanne N Lissenberg-Thunnissen; David J J de Gorter; Cornelis F M Sier; Inger B Schipper
Journal:  Int Orthop       Date:  2011-06-23       Impact factor: 3.075

View more
  7 in total

Review 1.  Applications of alginate microspheres in therapeutics delivery and cell culture: Past, present and future.

Authors:  Dinesh Dhamecha; Rachel Movsas; Ugene Sano; Jyothi U Menon
Journal:  Int J Pharm       Date:  2019-08-14       Impact factor: 5.875

Review 2.  Biomimetic hydrogels with spatial- and temporal-controlled chemical cues for tissue engineering.

Authors:  Weilue He; Max Reaume; Maureen Hennenfent; Bruce P Lee; Rupak Rajachar
Journal:  Biomater Sci       Date:  2020-06-03       Impact factor: 6.843

3.  An elastin-based vasculogenic scaffold promotes marginal islet mass engraftment and function at an extrahepatic site.

Authors:  Silvia Minardi; Michelle Guo; Xiaomin Zhang; Xunrong Luo
Journal:  J Immunol Regen Med       Date:  2018-12-10

Review 4.  Effect of Angiogenesis in Bone Tissue Engineering.

Authors:  Jianhao Huang; Qixiu Han; Meng Cai; Jie Zhu; Lan Li; Lingfeng Yu; Zhen Wang; Gentao Fan; Yan Zhu; Jingwei Lu; Guangxin Zhou
Journal:  Ann Biomed Eng       Date:  2022-05-07       Impact factor: 3.934

5.  E3 ligase HUWE1 promotes PDGF D-mediated osteoblastic differentiation of mesenchymal stem cells by effecting polyubiquitination of β-PDGFR.

Authors:  Tri Pham; Abdo J Najy; Hyeong-Reh C Kim
Journal:  J Biol Chem       Date:  2022-04-25       Impact factor: 5.486

Review 6.  Biologics and their delivery systems: Trends in myocardial infarction.

Authors:  Matthew A Borrelli; Heth R Turnquist; Steven R Little
Journal:  Adv Drug Deliv Rev       Date:  2021-03-26       Impact factor: 17.873

7.  The Stability Maintenance of Protein Drugs in Organic Coatings Based on Nanogels.

Authors:  Hongzhao Qi; Lijun Yang; Peipei Shan; Sujie Zhu; Han Ding; Sheng Xue; Yin Wang; Xubo Yuan; Peifeng Li
Journal:  Pharmaceutics       Date:  2020-02-01       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.